Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Filgrastim Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Lyophilized Powder
  • 1.3.3 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Filgrastim Market Share by Application (2019-2025)
  • 1.4.2 Solid Tumor
  • 1.4.3 Lymphoma
  • 1.4.4 Kidney Cancer
  • 1.4.5 Lung Disease
  • 1.4.6 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Filgrastim Market Size
  • 2.1.1 Global Filgrastim Revenue 2014-2025
  • 2.1.2 Global Filgrastim Sales 2014-2025
• 2.2 Filgrastim Growth Rate by Regions
  • 2.2.1 Global Filgrastim Sales by Regions 2014-2019
  • 2.2.2 Global Filgrastim Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Filgrastim Sales by Manufacturers
  • 3.1.1 Filgrastim Sales by Manufacturers 2014-2019
  • 3.1.2 Filgrastim Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Filgrastim Revenue by Manufacturers (2014-2019)
  • 3.2.2 Filgrastim Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Filgrastim Market Concentration Ratio (CR5 and HHI)
• 3.3 Filgrastim Price by Manufacturers
• 3.4 Key Manufacturers Filgrastim Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Filgrastim Market
• 3.6 Key Manufacturers Filgrastim Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Lyophilized Powder Sales and Revenue (2014-2019)
  • 4.1.2 Others Sales and Revenue (2014-2019)
• 4.2 Global Filgrastim Sales Market Share by Type
• 4.3 Global Filgrastim Revenue Market Share by Type
• 4.4 Filgrastim Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Filgrastim Sales by Application

6 United States

• 6.1 United States Filgrastim Breakdown Data by Company
• 6.2 United States Filgrastim Breakdown Data by Type
• 6.3 United States Filgrastim Breakdown Data by Application

7 European Union

• 7.1 European Union Filgrastim Breakdown Data by Company
• 7.2 European Union Filgrastim Breakdown Data by Type
• 7.3 European Union Filgrastim Breakdown Data by Application

8 China

• 8.1 China Filgrastim Breakdown Data by Company
• 8.2 China Filgrastim Breakdown Data by Type
• 8.3 China Filgrastim Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Filgrastim Breakdown Data by Company
• 9.2 Rest of World Filgrastim Breakdown Data by Type
• 9.3 Rest of World Filgrastim Breakdown Data by Application
• 9.4 Rest of World Filgrastim Breakdown Data by Countries
  • 9.4.1 Rest of World Filgrastim Sales by Countries
  • 9.4.2 Rest of World Filgrastim Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Amgen
  • 10.1.1 Amgen Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Filgrastim
  • 10.1.4 Filgrastim Product Introduction
  • 10.1.5 Amgen Recent Development
• 10.2 SANDOZ INC
  • 10.2.1 SANDOZ INC Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Filgrastim
  • 10.2.4 Filgrastim Product Introduction
  • 10.2.5 SANDOZ INC Recent Development
• 10.3 Teva
  • 10.3.1 Teva Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Filgrastim
  • 10.3.4 Filgrastim Product Introduction
  • 10.3.5 Teva Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Filgrastim Sales Channels
  • 11.2.2 Filgrastim Distributors
• 11.3 Filgrastim Customers

12 Market Forecast

• 12.1 Global Filgrastim Sales and Revenue Forecast 2019-2025
• 12.2 Global Filgrastim Sales Forecast by Type
• 12.3 Global Filgrastim Sales Forecast by Application
• 12.4 Filgrastim Forecast by Regions
  • 12.4.1 Global Filgrastim Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Filgrastim Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Granulocyte - colony stimulating factor (G-CSF) is another name for filgrastim. In some cases, health care professionals may use the trade name Neupogen, Granix or Zarxio when referring to the generic drug name filgrastim.
In 2019, the market size of Filgrastim is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Filgrastim.

This report studies the global market size of Filgrastim, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Filgrastim sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Amgen
SANDOZ INC
Teva
...

Market Segment by Product Type
Lyophilized Powder
Others

Market Segment by Application
Solid Tumor
Lymphoma
Kidney Cancer
Lung Disease
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Filgrastim status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Filgrastim manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Filgrastim are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025